TBA

  • Webinar recorded on Mon 12th November, 2012
  • 1 hours 23 mins
  • No Comments

For all of us involved in the use of antimicrobials, the feeling of unpredictability about their future continues to grow. What seems certain is that the regulatory environment is going to change, and we can expect some constraints on the way we prescribe and dispense these products very soon, and the presentation will survey the situation to-day and predict what may (may not) happen in the future. The availability of antimicrobials in veterinary practice in the years ahead is without doubt dependent on whether we as a profession are seen to handle these products responsibly and the webinar will discuss in detail how we must respond to this challenge, paying particular attention to the new requirements for their use under the new RCVS Code on Professional Conduct and the Practice Standards Scheme.

Born and raised in North Wales Peter left the Sir Huw Owen School in Caernarfon to attend University in Liverpool after which he returned to Wales for a spell in mixed practice followed by small animal practice in London, then Ontario in Canada, and back to west London. After several years in practice he joined the pharmaceutical industry and spent the next 18 years in the animal health business both in the UK and overseas.

Working for Lilly Research/Elanco and MSD AgVet in the fields of research/development and regulatory affairs Peter feels a sense of pride in having played a part in helping to research and develop some of the most advanced and innovative medicinal products available today, and which have made a significant contribution to animal health and welfare worldwide.

Returning to the UK from the USA in 1995 Peter joined the European institutions and was appointed the first head of the Veterinary Division at the newly created European Medicines Evaluation Agency (EMEA) in London. The chance of playing a leading role in the creation of the new European regulatory system and working at the centre of the European institutions gave him an invaluable insight and understanding of how things work in the EU.

Peter’s last post before semi-retirement in 2008 was as head of the global animal health industry association, the International Federation of Animal Health (IFAH) in Brussels whose goal is to act as a unified, global voice in dealings with governments, food industry partners and consumers. In this role he worked closely with the World Association of Animal Health (OIE), and the Food and Agricultural Organization of the UN, and served as a member of the OIE working parties on antimicrobial resistance and guidelines for vaccination for the control of Avian Influenza.

Within the BVA Peter has served on the Veterinary Policy Group and as chair of the Medicines Group. He has been secretary and chairman of the Association of Veterinarians in Industry, and participates in the work of the Federation of Veterinarians of Europe (FVE). At the Royal College of Veterinary Surgeons (RCVS) he was a member of the working group charged with rewriting the Guide to Professional Conduct, giving him an insight into the issues faced by practitioners today, and now serves on the RCVS Performance Protocol Working Party

Peter also acts as a consultant to GALVmed, a not-for-profit global alliance of public private and government partners and a registered charity in Scotland whose aim is to make livestock vaccines, diagnostics and medicines accessible to those in developing countries for whom livestock is a lifeline.

Peter became President at the BVA annual Congress in September 2012.

Read More

Please consider one of the following membership levels to enable you to view this webinar...